1. Home
  2. ICCC vs FPAY Comparison

ICCC vs FPAY Comparison

Compare ICCC & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • FPAY
  • Stock Information
  • Founded
  • ICCC 1982
  • FPAY 2003
  • Country
  • ICCC United States
  • FPAY United States
  • Employees
  • ICCC N/A
  • FPAY N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • FPAY Diversified Commercial Services
  • Sector
  • ICCC Health Care
  • FPAY Consumer Discretionary
  • Exchange
  • ICCC Nasdaq
  • FPAY Nasdaq
  • Market Cap
  • ICCC 28.0M
  • FPAY 32.7M
  • IPO Year
  • ICCC 1987
  • FPAY N/A
  • Fundamental
  • Price
  • ICCC $3.66
  • FPAY $1.66
  • Analyst Decision
  • ICCC
  • FPAY Strong Buy
  • Analyst Count
  • ICCC 0
  • FPAY 2
  • Target Price
  • ICCC N/A
  • FPAY $3.25
  • AVG Volume (30 Days)
  • ICCC 14.5K
  • FPAY 191.6K
  • Earning Date
  • ICCC 11-13-2024
  • FPAY 11-14-2024
  • Dividend Yield
  • ICCC N/A
  • FPAY N/A
  • EPS Growth
  • ICCC N/A
  • FPAY N/A
  • EPS
  • ICCC N/A
  • FPAY N/A
  • Revenue
  • ICCC $23,838,002.00
  • FPAY $134,563,007.00
  • Revenue This Year
  • ICCC N/A
  • FPAY $25.65
  • Revenue Next Year
  • ICCC N/A
  • FPAY $9.38
  • P/E Ratio
  • ICCC N/A
  • FPAY N/A
  • Revenue Growth
  • ICCC 46.37
  • FPAY 24.46
  • 52 Week Low
  • ICCC $3.34
  • FPAY $0.97
  • 52 Week High
  • ICCC $5.59
  • FPAY $1.95
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 54.28
  • FPAY 65.54
  • Support Level
  • ICCC $3.40
  • FPAY $1.51
  • Resistance Level
  • ICCC $3.64
  • FPAY $1.76
  • Average True Range (ATR)
  • ICCC 0.16
  • FPAY 0.12
  • MACD
  • ICCC 0.01
  • FPAY 0.05
  • Stochastic Oscillator
  • ICCC 65.12
  • FPAY 85.07

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

Share on Social Networks: